(Q34362220)

1 August 2017

title

Quantitative analysis of EZH2 expression and its correlations with lung cancer patients' clinical pathological characteristics (English)

1 reference

1 August 2017

1 reference

Liyan Wan

1

1 reference

1 August 2017

Xiao Li

series ordinal

2

1 reference

1 August 2017

Hong Shen

series ordinal

3

1 reference

1 August 2017

Xiaoyan Bai

series ordinal

4

1 reference

1 August 2017

publication date

24 July 2012

1 reference

Clinical and Translational Oncology

1 August 2017

published in

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

132-138

1 reference

1 August 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

Interaction of Vav with ENX-1, a putative transcriptional regulator of homeobox gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

The role of EZH2 in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

mTORC1 signaling in Parkinson's disease and L-DOPA-induced dyskinesia: A sensitized matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

The Polycomb group protein EZH2 directly controls DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and metastasis in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

EZH2 silencing by RNA interference inhibits proliferation in bladder cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0897-9

HDAC inhibitors conquer Polycomb proteins

21 January 2018

1 reference

12 December 2020

The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors.

1 reference

12 December 2020

[Quantitative study of thyroid transcription factor-1 protein expression in lung carcinoma cell nucleus by tissue microarray]

1 reference

12 December 2020

Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.

1 reference

12 December 2020

Enhancer of zeste homologue 2 expression in breast carcinoma smears in relationship with p53, Ki-67 and other prognostic parameters

1 reference

12 December 2020

Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance

1 reference

12 December 2020

10.1007/S12094-012-0897-9

Identifiers

DOI

1 reference

1 August 2017

1 reference